Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens

Recruiting in Palo Alto (17 mi)

Overseen by Thomas H Newsom, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Newsom Eye & Laser Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

To evaluate visual outcomes and quality of vision following bilateral implantation of the Clareon PanOptix intraocular lens (IOL) targeted for emmetropia.

Eligibility Criteria

Inclusion Criteria

Note: Ocular criteria must be met in both eyes.

Presenting for uncomplicated bilateral cataract surgery and have an interest in spectacle independence using a trifocal IOL

Meet the requirements for on-label implantation of the trifocal IOL

Participant Groups

Group I: The Clareon™ PanOptix™ Trifocal (toric and non-toric models) Experimental Treatment 1 Intervention

Bilateral implantation with the Clareon PanOptix Trifocal (toric and non-toric models)

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Newsom Eye & Laser Center Sebring, FL

Who Is Running the Clinical Trial?

Newsom Eye & Laser Center Lead Sponsor

Sengi Collaborator

Sengi Industry Sponsor

References